Carna Health announced it has raised $8 million to expand global access to its chronic kidney disease screening and care management technology, following a strategic partnership with Siemens Healthineers to scale preventive kidney care worldwide.
The Boston-based digital health company said the financing included participation from Dr. Jay Rosan, Cenk Bekmezçi, Jose Pereyra, Mark Boulding, Brandon Salomon, Andrew Roosevelt, Jeff Lindsey, Joseph White, John Brooks, Elvis Ndansi and Dr. Salvatore Viscomi. Carna Health said it will use the capital to accelerate innovation and growth for its AI-enabled platform focused on early identification, monitoring and patient management for CKD.
The company said its recent agreement with Siemens Healthineers combines Carna Health’s digital platform with Siemens Healthineers’ global point-of-care diagnostics infrastructure to broaden access to kidney screening and follow-up care. Carna Health said it recently completed an initiative in Cameroon with Siemens Healthineers and NeoDocs that enrolled 35,000 individuals across the Southwest and Littoral regions.
Data from the company’s screening programs suggests that large-scale, cost-effective approaches can identify previously undiagnosed disease and create opportunities for earlier intervention. The company said it plans to launch multiple programs in the Philippines with major cities and leading healthcare systems, with a national initiative also under development in the Dominican Republic. Carna Health also said it intends to expand into the United States and Turkey.
Carna Health has received international recognition for its work, including selection for a United Nations-supported AI for Good publication, inclusion in the textbook Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care, and recognition as a finalist in the Fierce Life Sciences Innovation Awards.
KEY QUOTES:
“This funding enables us to continue global expansion, offering a transformative digital health platform that expands access to comprehensive chronic kidney disease (CKD) care. By integrating AI-driven solutions for early identification, monitoring, and patient management, we’re empowering patients and healthcare providers to navigate care pathways more effectively.”
Salvatore Viscomi, MD, Chief Executive Officer, Carna Health
“Chronic diseases present significant challenges, including late diagnoses and inadequate management. This funding will enable us to accelerate Carna Health’s mission to provide effective, accessible tools that empower both patients and healthcare clinicians to tackle these challenges head-on. Our goal is to show that Carna Health’s platform can be seamlessly implemented worldwide and integrated with any health system, ensuring we reach as many people as possible.”
Dr. Jay Rosan, Investor
“Reliable distribution and operational readiness are fundamental to the success of population health programs. Carna Health has developed a robust platform that functions effectively across diverse markets and infrastructure levels. Reaching this funding milestone enables a more coordinated, scalable approach to chronic disease management. We are pleased to partner with Carna Health to introduce this innovative solution to the Turkish market.”
Cenk Bekmezçi, Investor
